
浏览全部资源
扫码关注微信
400016 重庆,重庆医科大学附属第一医院肿瘤科
[李龙浩,E-mail: 149276764@qq.comLI Longhao, E-mail: 149276764@qq.com
收稿:2022-06-15,
修回:2022-08-13,
纸质出版:2022-10-15
移动端阅览
童潮旭, 张涛, 龚惠英, 等. 不同剂量分割放射治疗对直肠癌细胞促血管生成作用的比较研究[J]. 陆军军医大学学报, 2022,44(19):1979-1987.
Chaoxu TONG, Tao ZHANG, Huiying GONG, et al. Comparison of angiogenetic effects of different dose fractionated radiotherapy on rectal cancer cells[J]. Journal of Army Medical University, 2022, 44(19): 1979-1987.
童潮旭, 张涛, 龚惠英, 等. 不同剂量分割放射治疗对直肠癌细胞促血管生成作用的比较研究[J]. 陆军军医大学学报, 2022,44(19):1979-1987. DOI: 10.16016/j.2097-0927.202206093.
Chaoxu TONG, Tao ZHANG, Huiying GONG, et al. Comparison of angiogenetic effects of different dose fractionated radiotherapy on rectal cancer cells[J]. Journal of Army Medical University, 2022, 44(19): 1979-1987. DOI: 10.16016/j.2097-0927.202206093.
目的
2
探讨不同剂量分割放射治疗对直肠癌肿瘤内血管生成的影响及其潜在机制。
方法
2
收集2017-2020年重庆医科大学附属第一医院肿瘤科收治的56例直肠癌患者病理学资料进行统计学分析,采用免疫组化检测大分割放疗(5 Gy×5次,1周内完成)和常规分割放疗(2 Gy×25次,5周内完成)后直肠癌患者癌组织中微血管密度,并使用Western blot检测癌组织中的低氧诱导因子-1α(hypoxia inducible factor 1-alpha,HIF-1α)和血管内皮生长因子(vascular endothelial growth factor,VEGF)蛋白表达水平。将培养的直肠癌细胞及人脐静脉内皮细胞分为0、4、12、24 Gy剂量辐照组,采用CCK-8法检测两种细胞各剂量辐照组的增殖情况,Western blot检测各剂量辐照组直肠癌细胞中VEGF和HIF-1α蛋白表达水平,ELISA检测直肠癌细胞上清液中VEGF的浓度。收集各剂量辐照组的直肠癌细胞条件培养基,干预培养并用CCK-8法和克隆形成实验观测人脐静脉内皮细胞的增殖情况。
结果
2
常规分割放疗组和大分割放疗组在病理肿瘤退缩分级(tumor regression grade,TRG)上差异无统计学意义,直肠癌患者术后癌组织免疫组化显示,大分割放疗组微血管密度计数(microvessel density,MVD,32.00±3.61)显著高于常规分割放疗组(22.33±3.06,
P
<
0.05);Western blot结果显示,大分割放疗组癌组织内HIF-1α和VEGF蛋白表达水平显著高于常规分割放疗组(
P
<
0.01)。细胞实验结果显示,不同剂量放射照射后,呈剂量依赖性降低直肠癌细胞和血管内皮细胞的增殖能力(
P
<
0.05)。直肠癌细胞中VEGF和HIF-1α的蛋白表达水平和直肠癌细胞上清液中VEGF的蛋白浓度随着辐照剂量的增加逐渐升高(
P
<
0.01)。大剂量辐照后直肠癌细胞培养基干预人脐静脉内皮细胞能显著提高其增殖能力(
P
<
0.01)。
结论
2
大剂量放疗能抑制血管内皮细胞增殖,同时可能通过促进直肠癌细胞HIF-1α和VEGF高表达,导致肿瘤血管代偿性生成增加。
Objective
2
To explore the effects of different dose fractionated radiotherapy on angiogenesis in rectal cancer and its potential mechanism.
Methods
2
The pathological data of 56 rectal cancer patients admitted to our hospital from 2017 to 2020 were collected for statistical analysis. The microvessel density (MVD) in the rectal cancer tissues under hypofractionated radiotherapy (HFR) and conventional fractionated radiotherapy (CFR) were respectively detected by immunohistochemistry. The expression levels of hypoxia inducible factor 1-alpha (HIF-1α) and vascular endothelial growth factor (VEGF) in the rectal cancer tissues were determined by Western blotting. Then the cultured rectal cancer SW1463 cells and human umbilical vein endothelial cells (HUVECs) were irradiated at doses of 0
4
12 and 24 Gy
respectively. CCK-8 assay was subsequently used to test the proliferation of both cells in each group
Western blotting was performed to measure the levels of VEGF and HIF-1α in SW1463 cells
and ELISA assay was adopted to detect the concentration of VEGF in the supernatant of rectal cancer cells. In addition
CCK-8 assay and colony formation assay were carried out to observe the proliferation of HUVECs after intervened with different doses of irradiated cultured medium.
Results
2
Chi
-square test showed no significant difference in pathological tumor regression grade (TRG) between the HFR and CFR groups. The results of immunohistochemistry indicated that the MVD in the HFR group (32.00±3.61) was significantly higher than that in the CFR group (22.33±3.06
P
<
0.05). Western blotting also revealed the protein levels of HIF-1α and VEGF were remarkably up-regulated in the HFR group (
P
<
0.01). In
in vitro
study
high-dose radiation dose-dependently reduced the proliferation of SW1463 cells and HUVECs (
P
<
0.05). However
the expression levels of VEGF and HIF-1α in rectal cancer cells and the content of VEGF in the supernatant were increased gradually with the rise of irradiation dose (
P
<
0.01). Correspondingly
the proliferation of H
UVEC cells was prominently enhanced by the cultured medium of rectal cancer cells after high-dose radiation (
P
<
0.01).
Conclusion
2
High-dose radiotherapy inhibits the proliferation of vascular endothelial cells
while may simultaneously increase the compensatory angiogenesis of tumor vessels by promoting the expression of HIF-1α and VEGF in rectal cancer cells.
苏文雨, 房静远. 2020年结直肠癌的研究新进展[J]. 中华医学信息导报, 2021, 36(3): 12-13. DOI: 10.3760/cma.j.issn.1000-8039.2021.03.107.
SU W Y, FANG J Y. New progress in colorectal cancer research in 2020[J]. Chin Med Information Guide, 2021, 36(3): 12-13. DOI: 10.3760/cma.j.issn.1000-8039.2021.03.107.
WU S G, ZHANG W W, SUN J Y, et al . Preoperative radiotherapy improves survival in rectal signet-ring cell carcinoma-a population-based study[J ] . Radiat Oncol, 2017, 12(1): 141. DOI: 10.1186/s13014-017-0874-0.
GOLLINS S, WEST N, SEBAG-MONTEFIORE D, et al . Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations[J ] . Br J Cancer, 2017, 117(9): 1286-1294. DOI: 10.1038/bjc.2017.294.
彭俊杰, 朱骥, 刘方奇, 等. 中国局部进展期直肠癌诊疗专家共识[J]. 中国癌症杂志, 2017, 27(1): 41-80. DOI: 10.19401/j.cnki.1007-3639.2017.01.008.
PENG J J, ZHU J, LIU F Q, et al . Expert consensus on diagnosis and treatment of locally advanced rectal cancer in China[J ] . China Oncol, 2017, 27(1): 41-80. DOI: 10.19401/j.cnki.1007-3639.2017.01.008.
ERLANDSSON J, HOLM T, PETTERSSON D, et al . Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm Ⅲ): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial[J ] . Lancet Oncol, 2017, 18(3): 336-346. DOI: 10.1016/S1470-2045(17)30086-4.
ZHANG Y Y, CHEN B, DING Y Q. Metastasis-associated factors facilitating the progression of colorectal cancer[J]. Asian Pac J Cancer Prev, 2012, 13(6): 2437-2444. DOI: 10.7314/apjcp.2012.13.6.2437.
SUN W, WANG X J, LI J L, et al . microRNA-181a promotes angiogenesis i n colorectal cancer by targeting SRCIN 1 to promote the SRC/VEGF signaling pathway[J ] . Cell Death Dis, 2018, 9(4): 438. DOI: 10.1038/s41419-018-0490-4..
KIM S, LEE M, CHOI Y K. The role of a neurovascular signaling pathway involving hypoxia-inducible factor and Notch in the function of the central nervous system[J]. Biomol Ther (Seoul), 2020, 28(1): 45-57. DOI: 10.4062/biomolther.2019.119.
TIRPE A A, GULEI D A, CIORTEA S M, et al . Hypoxia: overview on hypoxia-mediated mechanisms with a focus on the role of HIF genes[J ] . Int J Mol Sci, 2019, 20(24): 6140. DOI: 10.3390/ijms20246140.
VIALLARD C, LARRIVÉE B. Tumor angiogenesis and vascular normalization: alternative therapeutic targets[J]. Angiogenesis, 2017, 20(4): 409-426. DOI: 10.1007/s10456-017-9562-9.
ZHU H J, ZHANG S L. Hypoxia inducible factor-1α/vascular endothelial growth factor signaling activation correlates with response to radiotherapy and its inhibition reduces hypoxia-induced angiogenesis in lung cancer[J]. J Cell Biochem, 2018, 119(9): 7707-7718. DOI: 10.1002/jcb.27120.
CHABOWSKI M, NOWAK A, GRZEGRZOLKA J, et al . Comparison of microvessel density using nestin and CD34 in colorectal cancer[J ] . Anticancer Res, 2018, 38(7): 3889-3895. DOI: 10.21873/anticanres.12673.
MAEDA A, CHEN Y H, BU J C, et al . In vivo imaging reveals significant tumor vascular dysfunction and increased tumor hypoxia-inducible factor-1α expression induced by high single-dose irradiation in a pancreatic tumor model[J ] . Int J Radiat Oncol, 2017, 97(1): 184-194. DOI: 10.1016/j.ijrobp.2016.09.005..
SUNG H, FERLAY J, SIEGEL R L, et al . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J ] . CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660.
常娜, 钱立庭, 赵于飞, 等. 放疗技术在直肠癌术前治疗中的应用与研究进展[J]. 中国肿瘤, 2019, 28(11): 861-868. DOI: 10.11735/j.issn.1004-0242.2019.11.A009.
CHANG N, QIAN L T, ZHAO Y F, et al . Application of radiotherapy in preoperative treatment of rectal cancer[J ] . China Cancer, 2019, 28(11): 861-868. DOI: 10.11735/j.issn.1004-0242.2019.11.A009.
万觉锋, 章真. 直肠癌术前放疗进展[J]. 中华结直肠疾病电子杂志, 2016, 5(2): 127-132. DOI: 10.3877/cma.j.issn.2095-3224.2016.02.04.
WAN J F, ZHANG Z. Advances in preoperative radiation of locally advanced rectal cancer[J]. Chin J Colorectal Dis Electron Ed, 2016, 5(2): 127-132. DOI: 10.3877/cma.j.issn.2095-3224.2016.02.04.
ANSARI N, SOLOMON M J, FISHER R J, et al . Acute adverse events and postoperative complications in a randomized trial of preoperative short-course radiotherapy versus long-course chemoradiotherapy for T3 adenocarcinoma of the rectum: trans-Tasman radiation oncology group trial (TROG 01.04)[J ] . Ann Surg, 2017, 265(5): 882-888. DOI: 10.1097/SLA.0000000000001987.
ZHAN T C, GU J, LI M, et al . Intermediate-fraction neoadjuvant radiotherapy for rectal cancer[J ] . Dis Colon Rectum, 2013, 56(4): 422-432. DOI: 10.1097/DCR.0b013e31828576c6.
TSAI H C, TZENG H E, HUANG C Y, et al . WISP-1 positively regulates angiogenesis by controlling VEGF-A expression in human osteosarcoma[J ] . Cell Death Dis, 2017, 8(4): e2750. DOI: 10.1038/cddis.2016.421.
YANG J G, WANG L L, MA D C. Effects of vascular endothelial growth factors and their receptors on megakaryocytes and platelets and related diseases[J]. Br J Haematol, 2018, 180(3): 321-334. DOI: 10.1111/bjh.15000.
LUDWIG N, WHITESIDE T L. Potential roles of tumor-derived exosomes in angiogenesis[J]. Expert Opin Ther Targets, 2018, 22(5): 409-417. DOI: 10.1080/14728222.2018.1464141.
郭靖, 尚杨杨, 汪荣泉. 结直肠癌及缺氧的结直肠癌细胞中HIF-1α与miRNA-200b表达的相关性[J]. 第三军医大学学报, 2016, 38(6): 545-549. DOI: 10.16016/j.1000-5404.201510122.
GUO J, SHANG Y Y, WANG R Q. Correlation of HIF-1α and miRNA-200b expression in human colorectal cancer tissues and hypoxia-induced colorectal cancer cells[J]. J Third Mil Med Univ, 2016, 38(6): 545-549. DOI: 10.16016/j.1000-5404.201510122.
胥芸芸, 洪梅, 李桂香. 放疗对机体抗肿瘤免疫效应机制的影响[J]. 现代肿瘤医学, 2016, 24(24): 4023-4025. DOI: 10.3969/j.issn.1672-4992.2016.24.040.
XU Y Y, HONG M, LI G X. New progress on the effect of radiotherapy on the anti-tumor immune response[J]. J Mod Oncol, 2016, 24(24): 4023-4025. DOI: 10.3969/j.issn.1672-4992.2016.24.040.
FREY B, RVCKERT M, WEBER J, et al . Hypofrac-tionated irradiation has immune stimulatory potential and induces a timely restricted infiltration of immune cells in colon cancer tumors[J ] . Front Immunol, 2017, 8: 231. DOI: 10.3389/fimmu.2017.00231.
郑声琴, 范璟, 郑勤, 等. 单次大分割放疗在体外对树突状细胞激活T细胞的影响[J]. 东南大学学报(医学版), 2021, 40(1): 46-52. DOI: 10.3969/j.issn.1671-6264.2021.01.009.
ZHENG S Q, FAN J, ZHENG Q, et al . Effects of single fractionation radiotherapy on dendritic cells activation to T cell in vitro [J ] . J Southeast Univ Med Sci Ed, 2021, 40(1): 46-52. DOI: 10.3969/j.issn.1671-6264.2021.01.009..
PILON-THOMAS S, KODUMUDI K N, EL-KENAWI A E, et al . Neutralization of tumor acidity improves antitumor responses to immunotherapy[J ] . Cancer Res, 2016, 76(6): 1381-1390. DOI: 10.1158/0008-5472.CAN-15-1743.
SIA D, ALSINET C, NEWELL P, et al . VEGF signaling in cancer treatment[J ] . Curr Pharm Des, 2014, 20(17): 2834-2842. DOI: 10.2174/13816128113199990590.
FERRARA N, ADAMIS A P. Ten years of anti-vascular endothelial growth factor therapy[J]. Nat Rev Drug Discov, 2016, 15(6): 385-403. DOI: 10.1038/nrd.2015.17.
FUKUOKA S, HARA H, TAKAHASHI N, et al . Regorafenib plus nivolumab in patients with advanced gastric or colorectal cancer: an open-label, dose-escalation, and dose-expansion phase Ib trial (REGONIVO, EPOC1603)[J ] . J Clin Oncol, 2020, 38(18): 2053-2061. DOI: 10.1200/JCO.19.03296.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621